Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	50
Overall Study	STARTED	ABBV-154, 40mg SC	42
Overall Study	STARTED	ABBV-154, 150mg SC	45
Overall Study	STARTED	ABBV-154, 340mg SC	44
Overall Study	COMPLETED	Placebo	12
Overall Study	COMPLETED	ABBV-154, 40mg SC	8
Overall Study	COMPLETED	ABBV-154, 150mg SC	8
Overall Study	COMPLETED	ABBV-154, 340mg SC	7
Overall Study	NOT COMPLETED	Placebo	38
Overall Study	NOT COMPLETED	ABBV-154, 40mg SC	34
Overall Study	NOT COMPLETED	ABBV-154, 150mg SC	37
Overall Study	NOT COMPLETED	ABBV-154, 340mg SC	37

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04972968/flow